Public Calendar: July 28, 2019 - August 3, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
Event Date: 07/29/2019
Location: Washingtron, DC
Subject: Childhood Cancer Data Initiative Symposium - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, advocacy organizatins and members of the health care services field.
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 07/29/2019
Location: Silver Spring, MD
Subject: Contaminated Poppy Seeds
FDA Participant/Group: DAVID GOLDMAN; GRACE KIM; CATHERINE MCDERMOTT; CONRAD CHOINIERE;
Non FDA Participant/Group: Betty Hacala, Gary Underhill, Michelle Underhill, Steve Hacala (Consumers); Lovlean Purewal, Sarah Sorscher (Center for Science in Public Interest);
Event Date: 08/01/2019
Location: Washington, DC
Subject: Food and Beverage Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members of the food and beverage Industry
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 07/31/2019
Location: Mclean, VA
Subject: Duke Clinical Research Institute Conference: Designing and Testing Strategies for Implementing Evidence-Based Medicine
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 07/30/2019
Location: Washington, DC
Subject: National Press Foundation: CBER’s Efforts to Facilitate Vaccine Development
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 07/31/2019
Location: Denver, CO
Subject: America’s Blood Centers: FDA’s Approach to Risk and Benefit Considerations for the Blood Supply
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 07/31/2019
Location: Washington, DC
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the House Advisory Committee
Event Date: 08/01/2019
Location: Washington, DC
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Veterinary Medical Association House of Delegates
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event